A long-awaited amendment to the Czech Medicines Act came into force on 1 January 2024. What practical impact will it have?

Soltysinski Kawecki & Szlezak has advised Straumann Holding on its acquisition of Schmidt Dental from Oliver Schmidt. Burzak Okon and Partners reportedly advised Schmidt on the sale.

There has been much discussion about protracted shortages of critical medicines in the Czech Republic over the last couple of months. Many national measures have been adopted. At the European Union level,the Voluntary Solidarity Mechanism for medicines has been put in place.

PRK Partners has advised Affimed on its successful divestment of AbCheck to Flagship Pioneering company Ampersand Biomedicines.

Dan Minoiu has become a new Deputy Managing Partner at Musat & Asociatii, while Ana Maria Abrudan, Mateea Codreanu, and Stefan Diaconescu have all been promoted to Partner positions.

Attorneys-at-Law Wojciech Kulczyk and Krzysztof Sikorski have been elevated to Partner positions with WKB Lawyers at the start of 2024.